Takeda Pharmaceutical dividend and valuation

4502 · TSE · JPY

Compare Takeda Pharmaceutical
¥6,973.00Change from previous close: +0.33%Absolute change: +¥23.00

Close · November 20, 2026

Valuation

Takeda Pharmaceutical paid ¥202.00 per share in dividends over the last 12 months (yield 2.9%). Next ex-dividend date: March 30, 2027. The P/E ratio is 312.4. The average price target of 16 analysts is ¥7,118.94.

Data as of November 21, 2026

Takeda Pharmaceutical compared with similar companies

Takeda Pharmaceutical's P/E (trailing 12 months): 312.4, +657% against the median of a group of 11 similar companies (41.2).

Takeda Pharmaceutical's metrics compared with similar companies
MetricTakeda PharmaceuticalMedian25th–75th percentileBand
P/E (trailing 12 months)312.441.226.8 – 83.7High
Forward P/E49.730.923.6 – 50.6Middle
EV/EBITDA11.824.617.9 – 39.4Low
Price/book1.504.643.35 – 11.9Low
Price/sales2.379.504.06 – 14.2Low
Gross margin64.8%75.9%64.1% – 84.0%Middle
Operating margin16.6%24.1%19.7% – 32.8%Low
Net margin0.9%17.8%13.0% – 32.2%Low
ROE0.6%15.2%13.5% – 19.8%Low
Debt/equity0.720.110.02 – 0.44High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Takeda Pharmaceutical: valuation over time

The dividend yield (2.9%) is below the median of the last 10 fiscal years (4.3%).

Takeda Pharmaceutical P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
Mar 2026¥5,664.00-¥96.75—¥200.003.5%
Mar 2025¥4,413.00¥67.2365.6¥196.004.4%
Mar 2024¥4,183.00¥91.1645.9¥188.004.5%
Mar 2023¥4,350.00¥201.9421.5¥180.004.1%
Mar 2022¥3,498.00¥145.8724.0¥180.005.1%
Mar 2021¥3,985.00¥238.9616.7¥180.004.5%
Mar 2020¥3,308.00¥28.25117.1¥180.005.4%
Mar 2019¥4,521.00¥139.8232.3¥180.004.0%
Mar 2018¥5,183.00¥237.5621.8¥180.003.5%
Mar 2017¥5,229.00¥146.2635.8¥180.003.4%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
¥11.14T
Enterprise value
¥16.08T
PEG
0.49
EV/revenue
3.43

Profitability and growth

ROA
3.3%
ROIC
3.9%
Revenue growth (year over year)
6.7%
Earnings growth (year over year)
-1,687.1%

Financial health

Total cash
¥418.53B
Total debt
¥5.36T
Current ratio
1.15
Quick ratio
0.51
Altman Z-Score
1.21
Piotroski F-Score
6.00

Dividends

Annual dividend per share
¥202.00
Dividend yield
2.9%
Payout ratio
905.0%
Ex-dividend date
March 30, 2027

Analysts and estimates

Average price target
¥7,118.94
Median price target
¥7,250.00
High price target
¥8,400.00
Low price target
¥5,800.00
Analysts with a price target
16
Consensus
Buy
Forward EPS
¥140.39
EPS estimate, current year
¥139.71

Shares and trading

Beta
0.08
Average volume
4.51M
Shares outstanding
1.6B
Float
1.58B
Institutional ownership
49.0%
Insider ownership
1.2%